Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue Française

M Zysman, F Chabot, P Devillier, B Housset… - Revue des Maladies …, 2016 - Elsevier
The Société de Pneumologie de Langue Française proposes a decision algorithm on long-
term pharmacological COPD treatment. A working group reviewed the literature published …

Профилактика обострений хронической обструктивной болезни легких

СН Авдеев - Пульмонология, 2016 - journal.pulmonology.ru
Аннотация Характерной чертой течения хронической обструктивной болезни легких
(ХОБЛ) является развитие обострений. Обострение ХОБЛ является одной из самых …

[HTML][HTML] Effects of inhaled corticosteroids/long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture …

KH Cho, YS Kim, JA Linton, CM Nam, Y Choi… - Respiratory …, 2017 - Elsevier
Background Both inhaled corticosteroids (ICS) and long-acting β-agonists (LABA) have
been recommended for the treatment of severe/moderate chronic obstructive pulmonary …

Protocol for the air purification for eosinophilic COPD study (APECS): a randomised controlled trial of home air filtration by HEPA

MS Saeed, CM Denoncourt, IA Chao, S Schortmann… - BMJ open, 2024 - bmjopen.bmj.com
Introduction Exposure to particulate matter (PM) pollution has been associated with lower
lung function in adults with chronic obstructive pulmonary disease (COPD). Patients with …

Inhaled treatment of COPD: a Delphi consensus statement

V Ninane, JL Corhay, P Germonpré… - … journal of chronic …, 2017 - Taylor & Francis
Background Global Initiative for Chronic Obstructive Lung Disease (GOLD) global strategy
(2015) provides guidance for the treatment of chronic obstructive pulmonary disease …

Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns

SA Brunton, DK Hogarth - Postgraduate Medicine, 2023 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity
and mortality globally. In the major revision of the Global Initiative for Chronic Obstructive …

Inhaled corticosteroid treatment in chronic obstructive pulmonary disease (COPD): boon or bane?

AG Kaplan - The Journal of the American Board of Family …, 2020 - Am Board Family Med
Inhaled corticosteroid (ICS)–based therapy is often used for patients with chronic obstructive
pulmonary disease (COPD). However, this approach is under scrutiny because of ICS …

[PDF][PDF] Отмена ингаляционных глюкокортикостероидов у пациентов с хронической обструктивной болезнью легких

СН Авдеев, ЗР Айсанов, ВВ Архипов, АС Белевский… - Scopus, 2019 - elib.usma.ru
Резюме Роль ингаляционных глюкокортикостероидов (иГКС) в терапии пациентов с
хронической обструктивной болезнью легких (ХОБЛ) в современных клинических …

[HTML][HTML] Стратегии профилактики обострений хронической обструктивной болезни легких

СН Авдеев - Доктор. ру, 2017 - cyberleninka.ru
Цель обзора: рассмотреть этиологию, клинические последствия, средства
профилактики и лечения обострений хронической обструктивной болезни легких …

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts

SH Lee, JH Lee, HI Yoon, HY Park, TH Kim… - Respiratory …, 2019 - Springer
Background This cohort study of patients with chronic obstructive pulmonary disease
(COPD) was performed to evaluate the status of inhaled corticosteroid (ICS) prescriptions …